-
公开(公告)号:US09381215B2
公开(公告)日:2016-07-05
申请号:US14624325
申请日:2015-02-17
CPC分类号: A61K33/36 , A61K31/19 , A61K2300/00
摘要: The present invention provides a formulation comprising dichloroacetate and arsenic trioxide. The present invention also provides a method of treating cancer by administering a therapeutically effective amount of dichloroacetate and arsenic trioxide.
摘要翻译: 本发明提供包含二氯乙酸酯和三氧化二砷的制剂。 本发明还提供了通过施用治疗有效量的二氯乙酸盐和三氧化二砷来治疗癌症的方法。
-
公开(公告)号:US20150231176A1
公开(公告)日:2015-08-20
申请号:US14624325
申请日:2015-02-17
CPC分类号: A61K33/36 , A61K31/19 , A61K2300/00
摘要: The present invention provides a formulation comprising dichloroacetate and arsenic trioxide. The present invention also provides a method of treating cancer by administering a therapeutically effective amount of dichloroacetate and arsenic trioxide.
摘要翻译: 本发明提供包含二氯乙酸酯和三氧化二砷的制剂。 本发明还提供了通过施用治疗有效量的二氯乙酸盐和三氧化二砷来治疗癌症的方法。
-
3.
公开(公告)号:US06828347B2
公开(公告)日:2004-12-07
申请号:US10288685
申请日:2002-11-06
IPC分类号: C07D30777
摘要: This invention provides various biquinone and trimeric quinone derivatives. The invention also provides a method for synthesis of a multi-quinone compound including reacting a hydroxyquinone anion with a first quinone possessing a first directing group at a C-2 of the first quinone and a second directing group at a C-3 of the first quinone and obtaining a biquinone having one of the first and second directing groups at a C-3 of a first quinone monomer and a hydroxyl group at a C-3′ of a second quinone monomer. The biquinone can be further reacted to obtain various biquinone derivatives or with a second hydroxyquinone anion to obtain trimeric quinone derivatives, including trimeric naphthoquinone derivatives. The biquinones and trimeric quinones of this invention demonstrate antiviral activity and can be used to treat viral infections, particularly HIV infections.
摘要翻译: 本发明提供了各种双醌和三聚醌衍生物。 本发明还提供了一种合成多醌化合物的方法,包括使羟基醌阴离子与第一醌的C-2上具有第一定向基团的第一醌反应,第二定向基团在第一个醌的C-3处 醌,得到在第一醌单体的C-3和第二醌单体的C-3'的羟基上具有第一和第二导向基团之一的双醌。 可以进一步反应该双醌以获得各种双醌衍生物或第二羟基醌阴离子,得到三聚醌衍生物,包括三聚萘醌衍生物。 本发明的双醌和三聚醌表现出抗病毒活性,可用于治疗病毒感染,特别是HIV感染。
-
公开(公告)号:US20130109643A1
公开(公告)日:2013-05-02
申请号:US13697097
申请日:2011-05-10
申请人: Gregory Joseph Riggins , Meghan Joyce Seltzer , Takashi Tsukamoto , Chi Van Dang , Ashkan Emadi
发明人: Gregory Joseph Riggins , Meghan Joyce Seltzer , Takashi Tsukamoto , Chi Van Dang , Ashkan Emadi
IPC分类号: A61K31/433 , A61K31/704
CPC分类号: A61K31/433 , A61K31/704
摘要: Methods for treating a cancer having a mutant isocitrate dehydrogenase (IDH), including, but not limited to, a malignant low-grade glioma, a secondary glioblastoma, a transforming myeloproliferative disorder (tMPD), and an acute myelogenous leukemia (AML), with a glutaminase inhibitor, including, bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES), are disclosed.
摘要翻译: 用于治疗具有突变异柠檬酸脱氢酶(IDH)的癌症的方法,包括但不限于恶性低级胶质瘤,继发性胶质母细胞瘤,转化性骨髓增生性疾病(tMPD)和急性骨髓性白血病(AML),其具有 包括二-2-(5-苯基乙酰氨基-1,2,4-噻二唑-2-基)乙基硫醚(BPTES)的谷氨酰胺酶抑制剂。
-
-
-